VERVE-101

· Verve Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VERVE-101, covering 2025-05-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Disease